Lifespan Extension Advocacy FoundationBrent Nally of Lifespan.io interviews Dr. Andrew Steele, author of the new book “Ageless”. Andrew discusses why he made the switch from physics to aging research, confronting one’s own aging, and about the future of anti-aging biotechnology.
Dr. Steele’s book, “Ageless”, is an introduction to the cutting-edge research being performed in laboratories and universities across the world to slow or reverse the biological processes of aging.
Andrew Steele holds a Ph.D. in physics from Oxford University and currently working in the field of computational biology. He is currently a full-time science writer and presenter.
Lifespan.io is a non-profit organization focused on aging research and promoting healthy human longevity through the development of rejuvenation biotechnology and regenerative medicine.
From Physics To Aging Research - Dr. Andrew Steele - The Future Of Anti-aging BiotechnologyLifespan Extension Advocacy Foundation2021-12-10 | Brent Nally of Lifespan.io interviews Dr. Andrew Steele, author of the new book “Ageless”. Andrew discusses why he made the switch from physics to aging research, confronting one’s own aging, and about the future of anti-aging biotechnology.
Dr. Steele’s book, “Ageless”, is an introduction to the cutting-edge research being performed in laboratories and universities across the world to slow or reverse the biological processes of aging.
Andrew Steele holds a Ph.D. in physics from Oxford University and currently working in the field of computational biology. He is currently a full-time science writer and presenter.
Lifespan.io is a non-profit organization focused on aging research and promoting healthy human longevity through the development of rejuvenation biotechnology and regenerative medicine.
#AndrewSteele #RejuvenationBiotechnologies #Ageless #Longevity #ReversingCellAge #FromPhysicsToAgingResearch #TheFutureOfAnti-agingBiotechnologyMaxwell Biosciences: Ask Me Anything with CEO, J. Scotch Mcclure at EARD 2023Lifespan Extension Advocacy Foundation2024-10-17 | J. Scotch Mcclure, CEO of Maxwell Biosciences at the Longevity+DeSci Summit NYC (EARD 2023).
SUMMARY ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Mr. McClure is an experienced engineer, CEO, and corporate board director with a background in military intelligence and commercial technology. He is an inventor with patents in antiviral applications and human gene expression technology, and has led engineering and scientific research teams. His accomplishments include designing the world's first dual-core laptop and pioneering work in plasma proteomics and biomimetic drug design. With a diverse educational background including a B.S. in Management from the USAF Academy and an MBA from the University of Massachusetts, Mr. McClure served in the United States Air Force for nearly a decade in classified intelligence project management roles.
Maxwell Biosciences is a preclinical stage drug platform company partnering with large pharma companies to develop an entirely new class of patented low molecular weight drug candidates that destroy SARS-CoV-2, the COVID virus, as well as other viruses and infectious pathogens (including fungal and bacterial pathogens). Maxwell's first-in-class CLAROMER™ brand drug discovery platform mimics natural human immune system antimicrobial and antiviral peptides. Maxwell Biosciences has benefitted from over $35M of non-dilutive grants and awards from governments around the world to validate their science and technology, including studies by US Govt-funded labs confirming that Maxwell's lead drug candidate has direct virucidal action against Herpes virus (HSV-1) and SARS-CoV-2, the COVID virus. Additionally, live mouse safety data at Texas A&M show Maxwell's drugs benefit from a tissue-safe toxicology profiles, and live mouse studies from the Baylor College of Medicine show breakthrough fungicidal action with CLAROMER™ brand compounds against lethal fungal infections of the upper-respiratory tract. These findings support the expected safety and effectiveness of Maxwell's “multi-asset, multi-target” anti-infectives drug platform. Maxwell's drug platform is supported by a granted patent portfolio and is strongly positioned in the fight against emergent viral pandemics and a broad spectrum of evolving infectious pathogens. Maxwell is raising funds for advanced preclinical and human trials.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenationAging Clocks, Entropy, and the Limits of Age-Reversal: Peter Fedichev at EARD 2023Lifespan Extension Advocacy Foundation2024-10-11 | Peter Fedichev, Co-Founder and CEO of Gero.ai presents "Aging Clocks, Entropy, and the Limits of Age-Reversal" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
About Peter Fedichev ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Dr. Fedichev is a scientist and entrepreneur with over 20 years of experience in academic research and the biotech industry, currently serving as the CEO of Gero.ai, a company developing AI-driven Large Health Models to combat aging and chronic diseases. With a background spanning physics and biology, including an M.S. in theoretical physics and a Ph.D. from the University of Amsterdam, they have authored more than 80 publications and made significant contributions to aging research, driven by a passion for scientific discovery and the ambitious goal of extending human healthspan and lifespan.
Gero.ai utilizes Whole-Exome Sequencing data for in-human AI Drug Discovery, while GeroSense is the arm of Gero creating Digital Biomarkers.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationHands-On Crypto Wallet Workshop by VitaDAO and Weavechain at EARD 2023Lifespan Extension Advocacy Foundation2024-09-19 | Hands-On Crypto Wallet Workshop by VitaDAO and Weavechain at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
In this video presentation entitled, "Blockchain 101: Getting Connected," you will learn more about the blockchain and how to utilize it from presenters Max Unfried and Alex Dobrin.
Maximilian Unfried, Ph.D. / @MaxUnfried -Researcher at National University Singapore https://nus.edu.sg/
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationNOVOS: Ask Me Anything Session at EARD 2023Lifespan Extension Advocacy Foundation2024-09-16 | NOVOS: Ask Me Anything Session at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
In this Ask Me Anything, Chris and Stephanie answer questions about the Consumer Longevity Biotech Company "NOVOS," as well as their approach to supplements and what it means to live a healthy lifestyle.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationThe Role of DeSci and DAOs in Engaging the World in Longevity Biotech: Panel Discussion at EARD 2023Lifespan Extension Advocacy Foundation2024-09-09 | Panel discussion "The Role of DeSci and DAOs in Engaging the World in Longevity Biotech" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
Maximilian Unfried, Ph.D. @MaxUnfried -Researcher - National University Singapore
This panel discussion at EARD 2023 focused on defining biomarkers of aging, exploring their biological significance, and the challenges of measuring biological age accurately. Experts emphasized the need for a comprehensive understanding of aging mechanisms and discussed various biomarkers, including epigenetic clocks and physiological measures, to improve interventions and clinical applications.
Matthew O'Connor -CEO of Scientific Affairs of Cyclarity Therapeutics / cyclaritytx.com
J Robertson -VP of Development of Prospera / prospera.co/en
This panel discussion at EARD 2023 explored regulatory breakthroughs in longevity and blockchain technology. Experts discussed the importance of bipartisan support for longevity initiatives, the need for innovative regulatory frameworks, and the challenges of navigating political landscapes. They emphasized the role of awareness, collaboration, and effective communication in advancing longevity research and policies.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationImpact DAOs Accelerate Cures for Alzheimers and Other Diseases of Aging: Brian Magierski EARD 2023Lifespan Extension Advocacy Foundation2024-08-12 | Brian Magierski, Founder - 21 Impact Labs presents "Impact DAOs to Accelerate Cures for Alzheimer's and Other Diseases of Aging" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
About Brian Magierski ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Bryan is a serial entrepreneur, co-founder and CEO/COO of multiple software startups. He successfully raised multiple rounds of VC/PE capital, bought and sold businesses, including the exit of a $340m software startup to a publicly traded company. He earned his Harvard MBA and received his BS from Cornell. Bryan is an advisory board member to Entrepreneurship@Cornell, board member at Trinity Episcopal School and the Rise School of Austin, and parent to child with Down syndrome.
21 Impact Labs is re-imagining impact funding for the 21st century by scaling communities, talent, and capital globally to advance brain longevity, and accelerate solutions and cures to Alzheimer’s disease. Through the use of crypto economic mechanisms and Web3 technologies, they will make impact funding more open, transparent, scalable, and democratic. They fundamentally believe that properly designed crypto economic mechanisms are the most powerful way to organize talent and capital on a global scale to pursue a common mission.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationBuilding the physical Infrastructure of Decentralized Science: Harry Gandhi at EARD 2023Lifespan Extension Advocacy Foundation2024-08-08 | Harry Gandhi, Venture Partner - 1517 Fund presents "Building the physical Infrastructure of Decentralized Science" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
About Harry Gandhi ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Harry helps founders build great companies - especially if they are focused on solving big and impactful problems. Harry is an entrepreneur who likes starting companies, avidly drinking tea, and playing (slightly) above average chess.
1517 is a venture capital fund and community supporting college dropouts solving hard problems and deep tech scientists with investment at the earliest stages of their companies. Founded by the cofounders of the Thiel Fellowship, it supports founders across software, hardware, and deep tech verticals and also provides a community to hackers, makers, and scientists from across the world.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationProtecting User Health Data and Bringing Biomarkers to the Public: Michael Geer at EARD 2023Lifespan Extension Advocacy Foundation2024-08-05 | Michael Geer, CEO - Humanity presents "Protecting User Health Data and Bringing Biomarkers to the Public" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
About Michael Geer ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Michael learned the consumer internet industry from the ground up while helping build badoo.com in Moscow and then set up a London office, constructing Badoo piece by piece scaling from 0 to 70 million users. He went on to build AnchorFree from a popular single app company when he joined, to leading global protector of the Internet with over 700 million users and hundreds of millions in yearly subscription revenue. Leveraging all those skills/experience, he embarked on the mission of his life by Co-founding Humanity with his close friend Peter Ward.
Humanity lets people of the world fight aging damage that robs them of a healthy long life and countless friends and family members. Just in the last 5 years the scientific community has made incredible steps forward in its understanding of what drives loss of function in our bodies over time (aging). Humanity will become a distributor of these solutions, feed data back into the research community and for the first time give its users a concrete feedback loop to track the effectiveness of each intervention/solution.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationThe BioAge Platform: From biomarkers to drug trials and back again: Eric Morgen, M.D. at EARD 2023Lifespan Extension Advocacy Foundation2024-08-01 | Eric Morgen, M.D. COO and Co-Founder - BioAge Labs presents "The BioAge Platform: From biomarkers to drug trials and back again" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
About Eric Morgen ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Dr. Eric Morgen Eric oversees BIOAGE’s clinical and computational efforts to bring new therapeutics to the clinic that target fundamental mechanisms of aging. Eric was previously an assistant professor at the University of Toronto, where his research focused on biomarker discovery and characterization in high-dimensional datasets from human cohorts. He completed an HBSc in artificial intelligence, MD, clinical training in pathology, and a research fellowship in computational biology and molecular epidemiology at the University of Toronto, where he held a Canada Graduate Scholarship from the CIHR, and was subsequently a CIHR research fellow. He has published over 15 papers in the areas of molecular biomarker discovery, pharmacogenomics, aging, and diagnostic medicine. Eric is a licentiate of the Medical Council of Canada, a fellow of the Royal College of Physicians and Surgeons of Canada, holds a specialty designation in pathology, and previously practiced medicine at Mount Sinai Hospital in Toronto.
BioAge Labs is harnessing the biology of human aging to develop new therapies for metabolic diseases. Their human-first discovery platform analyzes proprietary multi-omics data captured over decades to identify the molecular mediators of aging and disease.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationNew Paradigms to Improve Womens Reproductive Health: Laura Minquini, Founder - AthenaDao EARD 2023Lifespan Extension Advocacy Foundation2024-07-29 | Laura Minquini, Founder and Core Lead - AthenaDao presents "Leverage New Paradigms to Improve Women's Reproductive Health" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
About Laura Minquini ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Laura Minquini specializes in branding and business development. She launched and brought to market the first fashion-focused tech accessories, Case Scenario, achieved premium worldwide distribution, millions of dollars in sales, and became an Apple third party vendor within a year. She is experienced in bringing new products to market and marketing strategy. "I have a unique global vision and understanding of designed consumer experiences." Now, she is bringing her experience to AthenaDao as the Founder and Core Lead.
AthenaDao is a decentralized autonomous organization (DAO) focused on advancing women's health research. It aims to fund and support innovative projects related to female-specific health issues by leveraging blockchain technology and community-driven governance. The organization emphasizes transparency and collaboration, bringing together researchers, investors, and advocates to drive progress in women's health.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenation #womenshealth #blockchain #decentralizedscience #femtech #dao #womeninscienceDecentralization and Contract Research Organizations: Kelsey Moody, Ph.D. at EARD 2023Lifespan Extension Advocacy Foundation2024-07-25 | Kelsey Moody, Ph.D. presents "Decentralization and Contract Research Organizations" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
About Kelsey Moody ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Dr. Kelsey Moody is a process-oriented drug developer and executive who has specialized in the study of aging and aging mechanisms for over a decade. Since 2013, Dr. Moody has raised over $30 million in venture capital and successfully built Ichor Life Sciences (formerly Ichor Therapeutics) from a living room start-up into a premier, vertically integrated research organization. Dr. Moody holds a PhD from University of Miami's Miller School of Medicine in Biochemistry and Molecular Biology, and an MBA from Concordia University Wisconsin.
Ichor Life Sciences is a vertically integrated contract research organization occupying multiple commercial facilities with complete pre-clinical R&D capabilities in Syracuse, NY. Their mission is to help researchers spark the next generation of pharmaceuticals by driving profound protein discovery, developing robust pharmaceutical datasets, and consulting with clients to ensure lucrative outcomes.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationMaxwell Biosciences: J. Scotch Mcclure at EARD 2023Lifespan Extension Advocacy Foundation2024-07-18 | J. Scotch Mcclure of Maxwell Biosciences at the Longevity+DeSci Summit NYC (EARD 2023).
SUMMARY ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Mr. McClure is an experienced engineer, CEO, and corporate board director with a background in military intelligence and commercial technology. He is an inventor with patents in antiviral applications and human gene expression technology, and has led engineering and scientific research teams. His accomplishments include designing the world's first dual-core laptop and pioneering work in plasma proteomics and biomimetic drug design. With a diverse educational background including a B.S. in Management from the USAF Academy and an MBA from the University of Massachusetts, Mr. McClure served in the United States Air Force for nearly a decade in classified intelligence project management roles.
Maxwell Biosciences is a preclinical stage drug platform company partnering with large pharma companies to develop an entirely new class of patented low molecular weight drug candidates that destroy SARS-CoV-2, the COVID virus, as well as other viruses and infectious pathogens (including fungal and bacterial pathogens). Maxwell's first-in-class CLAROMER™ brand drug discovery platform mimics natural human immune system antimicrobial and antiviral peptides. Maxwell Biosciences has benefitted from over $35M of non-dilutive grants and awards from governments around the world to validate their science and technology, including studies by US Govt-funded labs confirming that Maxwell's lead drug candidate has direct virucidal action against Herpes virus (HSV-1) and SARS-CoV-2, the COVID virus. Additionally, live mouse safety data at Texas A&M show Maxwell's drugs benefit from a tissue-safe toxicology profiles, and live mouse studies from the Baylor College of Medicine show breakthrough fungicidal action with CLAROMER™ brand compounds against lethal fungal infections of the upper-respiratory tract. These findings support the expected safety and effectiveness of Maxwell's “multi-asset, multi-target” anti-infectives drug platform. Maxwell's drug platform is supported by a granted patent portfolio and is strongly positioned in the fight against emergent viral pandemics and a broad spectrum of evolving infectious pathogens. Maxwell is raising funds for advanced preclinical and human trials.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenationExploring Longevity: From Shrews to WhalesLifespan Extension Advocacy Foundation2024-07-17 | The lifespan of mammals can vary dramatically; shrews may live just two years, while some whales can navigate the oceans for over two centuries. But how does evolution shape such varied lifespans across species?
By studying and understanding the molecular mechanisms in short-lived and long-lived mammals we are able to explore new ways to potentially reverse biological aging in cells, tissues, or even entire organisms.
💬 We want to hear from you! What aspects of aging research excite you the most? Could the ability to rejuvenate biological systems change the way we approach healthcare and conservation?
Join the conversation below and let's dive deeper into the science of longevity! @lifespanio #LongevityResearch #AgingScience #Rejuvenation
Dr. Vadim Glayshev's LinkedIn: buff.ly/4cAjtAo Full Presentation: buff.ly/4f38eC2Aging Across Species with Epigenetic ClocksLifespan Extension Advocacy Foundation2024-07-13 | Is it possible to create a universal tool to measure aging in every mammal, from bats to whales, despite millions of years of evolutionary differences? The answer is a groundbreaking yes! Researchers have developed epigenetic clocks, a single mathematical model, using specific DNA markers called cytosines, capable of estimating age across all mammalian species without any hidden parameters. 🐋🦇
This leads us to an intriguing question: Is it easier to build such a clock for short-lived species like mice, or for long-lived species like humans or whales? Surprisingly, the effectiveness of epigenetic clocks remains consistent across species, regardless of their lifespan. This discovery opens new doors for understanding aging not just in humans but in all mammals. 🌐🔬
What implications do you think this could have for conservation efforts, veterinary medicine, or even human healthcare? Join the conversation below and share your thoughts on this fascinating advancement in science! @lifespanio #EpigeneticClocks #AgingResearch #CrossSpeciesScience
Dr. Steve Horvath's LinkedIn: buff.ly/4cWvqjB Full Presentation: buff.ly/3Y6E5M6Celebrating a Decade of Progress in LongevityLifespan Extension Advocacy Foundation2024-07-10 | Over the last ten years, the field of longevity science has seen exponential growth, highlighting the urgent need for a coherent strategy to unify all participants—from researchers and investors to policymakers and the wider community. Lifespan.io is proud to serve as the stewards of this progress.
Our mission is to equip the world with the necessary tools to navigate the complexities of longevity science. By fostering cross-pollination and accelerating innovative breakthroughs, we aim to turn challenges into opportunities for triumph.
As we continue to push the boundaries of what's possible, we're excited about the future and the serendipitous connections that will lead us to new heights in health and human lifespan.
We invite you to join us on this journey.
How do you see yourself contributing to the longevity field?
Share your vision and let's innovate together! #LongevityLeadership #DecadeOfDiscovery #FutureOfHealth
For more information and exciting updates in this cutting-edge field follow @lifespanioHacking Complex Diseases and Aging: Peter Fedichev at EARD 2023Lifespan Extension Advocacy Foundation2024-07-08 | Dr. Peter Fedichev of Gero.ai presents "Hacking Complex Diseases and Aging" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
About Peter Fedichev ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Dr. Peter Fedichev is a scientist and entrepreneur with over 20 years of experience in academic research and the biotech industry. Currently, he serves as the CEO of Gero.ai, a cutting-edge biotechnology company focused on using AI to understand and combat aging and chronic diseases. Gero.ai has developed proprietary physics-based machine learning models, known as Large Health Models (LHMs), to analyze human health data and predict health outcomes. These models distinguish the effects of aging from those of diseases, enabling more precise drug discovery and development. Their goal is to create therapies that not only treat age-related diseases but also potentially extend human healthspan and lifespan.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationThe Future of Philanthropy: Dynamic NFTsLifespan Extension Advocacy Foundation2024-07-06 | A revolutionary way to support longevity science and decentralized research: dynamic NFTs paired with game-based philanthropy.
Imagine an NFT that not only represents your commitment to a cause but evolves as you contribute more to the fight against age-related diseases. This is what we at Lifespan.io are pioneering with our "Proof of Philanthropy" prototype.
By merging aesthetics with altruism, these NFTs aim to inspire the public and generate tangible support for crucial research. It's a win-win: advance groundbreaking science while owning an art piece that reflects your philanthropic spirit.
How do you think dynamic NFTs can change the way we support and view charitable giving? Let us know in the comments! #LifespanIO #DynamicNFTs #GameBasedPhilanthropy #InnovateForHealth
Keith's Linkedin: buff.ly/3XGejOD Keith's Facebook: buff.ly/3VEolgG Watch the full presentation: buff.ly/3xOi225Join the Movement for Longevity with Lifespan.ioLifespan Extension Advocacy Foundation2024-07-03 | When we talk about longevity, we're not just envisioning a future of extended lifespans. Our mission goes deeper: we aim to reduce suffering and end age-related diseases. Whether you dream of transcending human limits or simply want a healthier, longer life, our goals align under a common cause.
Understanding aging is the first critical step, and achieving this requires significant funding, knowledge, and collaboration. We need a united voice to integrate these initiatives into mainstream discussions and actions effectively.
We're calling on everyone—advocates, researchers, and you. Together, we can tackle the challenges of aging head-on and create a future where everyone benefits from the advancements in longevity research.
How do you envision contributing to this cause? What does longevity mean to you?
Share your thoughts and let's amplify our impact together. #Longevity #EndAging #TogetherForHealth
For more information and exciting updates in this cutting-edge field follow @lifespanioFrom Crowdfunding to Cutting-Edge ResearchLifespan Extension Advocacy Foundation2024-06-29 | When Lifespan.io launched, we took inspiration from the early trailblazers in cancer research who transformed their cause into a national movement. Just like them, we started with a clear focus: crowdfunding dedicated exclusively to longevity research.
We began by identifying credible aging research to support. We then built a grassroots movement, rallying community aid to back these promising projects.
Now, embracing cutting-edge technologies, we are enhancing this strategy. We're integrating dynamic NFTs, regenerative funding models, and paving the way for decentralized clinical trials. These innovations promise to revolutionize how longevity research is conducted and funded.
As we continue to advance in the science of aging, we invite you to join us in this exciting journey.
What role do you see yourself playing in this transformative venture? Share your ideas and let's innovate together! #AgingResearch #InnovationInLongevity #LifespanIo
Keith's Linkedin: buff.ly/3XGejOD Keith's Facebook: buff.ly/3VEolgG Watch the full presentation: buff.ly/3xOi225Celebrating a Decade of Innovation with Lifespan.ioLifespan Extension Advocacy Foundation2024-06-26 | Over the past ten years, Lifespan.io has grown to become a leading nonprofit in the field of longevity science. Since our early days of crowdfunding and advocacy, we have expanded into the realms of education and news, consistently pushing the boundaries of how aging is perceived and understood.
We're not just a media platform; we're architects of connection, bridging the gap between individuals and organizations, and fostering collaborations that drive forward the science of longevity.
As we reflect on a decade of advocacy, we are excited about the future and the possibilities that lie ahead.
We want to hear from you! How has Lifespan.io impacted your understanding of longevity? #LifespanDecade #LongevityLeaders #FutureOfHealth
For more information and exciting updates in this cutting-edge field follow @lifespanioModifying Longevity In HumansLifespan Extension Advocacy Foundation2024-06-22 | Longevity in humans can potentially be modified through the discovery of biomarkers to measure aging processes and interventions to test the effectiveness of various treatments. With a focus on these two key elements, researchers can work towards understanding and potentially extending human lifespan. Fortunately, there is no shortage of interventions being explored in the quest for promoting longevity and healthy aging. Brian's Linkedin: buff.ly/3RCKE5l Facebook: buff.ly/4bdhVef Watch the full presentation: buff.ly/3xwQCObInnovation, Collaboration & CommunityLifespan Extension Advocacy Foundation2024-06-19 | At Lifespan.io we're dedicated to reshaping the conversation around science and health, tackling misconceptions while sparking curiosity. We aim to educate without oversimplifying, and to excite without overpromising.
Our collaboration with Chris Hemsworth's wellness brand, Centr, is a dynamic blend of science and stardom, bridging the gap between the scientific community and the broader public.
Together, we're exploring new horizons and demonstrating the power of innovative partnerships. This collaboration not only extends our reach but also amplifies our impact, showing what's possible when science meets celebrity.
We’d love to hear your thoughts: What are you most excited to see from this partnership?
Drop a comment below and join the conversation! @lifespanio @CentrFit @chrishemsworth #LifespanIO #Centr #ScienceMeetsCelebrity #MindMeetsBody #InnovationInHealthUniting Across Disciplines to Magnify Progress: Stephanie Dainow at EARD 2023Lifespan Extension Advocacy Foundation2024-05-31 | Stephanie Dainow of Lifespan.io presents "Uniting Across Disciplines to Magnify Progress" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
About Stephanie ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Stephanie Dainow is Executive Director at Lifespan.io [Lifespan Extension Advocacy Foundation], a US-based non-profit advocacy organization committed to accelerating biomedical technologies that will increase healthy human lifespan. The organization is well-known for responsible journalism, research, funding mechanisms, education, and decentralized science initiatives. Stephanie is also a Business Mentor to UC Davis' Venture Catalyst and SOSV's IndieBio venture fund and accelerator, consulting deep tech startup founders on business development and strategy, fundraising, and executive leadership. In 2022, she was given the Rising Star award at the Dublin Longevity Summit in recognition of her work in the aging and longevity field. Previously, Stephanie was with Singularity University in Silicon Valley, working across their Innovation Consultancy, Tech Think Tank, University for the Future, and Impact-based Startup Incubator. She's worked for a global management consultancy as a Life Sciences Business Manager and served as Account Director for BioMarin Pharmaceutical. Her early career in NYC spanned global growth for Interpublic Group's media arm, celebrity and brand marketing, and commercial entertainment. Stephanie has volunteered around the world and previously held an Advisory Board position at a 501(c)(3) that inspires Harlem youth to pursue STEM careers. She is passionate about empowering leaders to think differently about emerging technologies, disruption, and the future of corporate business.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationHarnessing Cell Reprogramming to Restore More Youthful Gene Expression: Yuri Deigin at EARD 2023Lifespan Extension Advocacy Foundation2024-05-21 | Yuri Deigin of YouthBio Therapeutics Inc. presents "Harnessing Cell Reprogramming to Restore More Youthful Gene Expression" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
About Yuri ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Yuri is a longevity biotech entrepreneur specializing in early-stage translation of scientific breakthroughs into therapies, particularly in the CNS space: previously, Yuri has led several early-stage pharmaceutical startups, including one developing an Alzheimer's therapeutic, and another developing small-molecule neuroprotectors for Alzheimer's, Parkinson's, and a rare pediatric disease. Currently, Yuri is leading YouthBio Therapeutics, which is developing epigenetic rejuvenation gene therapies based on partial cellular reprogramming by Yamanaka factors.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwards #cellrepair #cellularbiology #rejuvenationCrowdfunding and DeSciLifespan Extension Advocacy Foundation2024-05-09 | Traditional funding systems such as grants and venture capital tend to suffer from a culture of risk aversion. Funding frequently goes to research that has the greatest expected chance of success and thus the most likelihood of being published in scientific journals. Unfortunately, this leads to a situation that favors incremental progress, while more ambitious research, often with game-changing potential, fails to get funded.
Combine this problem with the fierce level of competition in the grant system, and it all adds up to potentially transformative technologies being left to languish. The research needed to defeat aging, and in doing so age-related diseases, is no exception to this problem. Innovative ideas and research directions that could move us closer to understanding and bringing aging under medical control need more funding. This dynamic has been called out by some of the leading researchers at top universities who highlight the fact that they have to abandon exciting, potentially groundbreaking studies because they are forced to go where the grant money is.
This is why we launched our own crowdfunding platform in 2015, which specifically supports aging and rejuvenation research. We have raised over $750,000 for important aging research and have worked with institutions including Harvard Medical School and SENS Research Foundation. The research we have helped to fund includes mitochondrial repair, DNA damage, functional biomarkers of aging, and a rapamycin human trial.
We support the decentralized science, or “DeSci” movement, which aims to increase scientific funding, to free knowledge from silos, and to cut out profit-motivated intermediaries such as publisher conglomerates that lock scientific data behind paywalls.
As part of our DeSci strategy, Lifespan.io is working on a variety of innovative Web3 efforts to raise funds and awareness for research aimed at extending healthy human lifespan. This includes, organizing the first-of-its-kind decentralized clinical trial for digital therapies targeting dementia, pioneering new forms of perpetual and NFT-based fundraising for public goods, and creating a massive-scale metaversal game to raise hundreds of millions for aging research.
On Lifespan.io, researchers can launch projects related to longevity or age-related diseases and receive funds from contributors to fulfill their goals. Contributors, in turn, are able to exercise agency in the development of potentially life-changing research and to receive rewards specified by the project creators. This works in a similar way to Kickstarter and other crowdfunding systems, only in this case, the funds go to aging and rejuvenation research.
If you have a project you’d like to crowdfund, please get in touch with us. We offer active support. And because we are a 501(c)(3) nonprofit organization and fiscally sponsor all project donations, contributors will automatically receive a tax receipt for donations made to your project. There are some potentially game-changing medical technologies on the horizon that could be truly transformative for healthcare and how we treat age-related diseases. By sponsoring, democratizing and funding aging research, we aim to accelerate progress towards this important goal for all humankind.Gamma Stimulation Promotes Amyloid ClearanceLifespan Extension Advocacy Foundation2024-04-01 | This Journal Club is on a paper demonstrating that noninvasive 40 Hz stimulation promotes 40 Hz neural activity in multiple brain regions and attenuates pathology in mouse models of Alzheimer’s disease. This is a subject close to our heart, as Dr. Medvedik and Lifespan.io are working on developing the Mindset project. This project aims to target Alzheimer’s disease using a headset that stimulates the brain with light and sound in order to trigger neural entrainment, thus reducing the loss of functional connectivity, combating brain atrophy, and improving cognitive function.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ LEAF / Lifespan.io is a 501(c)(3) nonprofit organization. Everything we've done thus far and everything we will do in the future is thanks to your support - please stand with us to fight the diseases of aging and increase healthy human lifespan. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero ► Make a one-time donation and learn about other ways to support us here: http://lifespan.io/support ► Learn more, and help us #CrowdsourceTheCure: lifespan.io ► Subscribe: http://www.youtube.com/user/LifespanIOKeynote: International Perspective on Human Longevity Trials, Aging & DeSci, Brian Kennedy EARD2023Lifespan Extension Advocacy Foundation2024-03-14 | Dr. Brian Kennedy of the National University of Singapore presents "An International Perspective on Human Longevity Trials, Aging, and DeSci" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
Summary ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Dr. Brian Kennedy is internationally recognized for his research in the basic biology of aging and as a visionary committed to translating research discoveries into new ways of delaying, detecting, and preventing human aging and associated diseases. He is a Professor in the Departments of Biochemistry and Physiology at National University Singapore and Director of the Centre for Healthy Ageing in the National University Health System. From 2010 to 2016 he was the President and CEO of the Buck Institute for Research on Aging. Currently, he remains as a Professor at the Institute. Dr. Kennedy also has an adjunct appointment at the USC Davis School of Gerontology. Dr. Kennedy is also actively involved Biotechnology companies, serving in consulting and Board capacities, as well as Scientific Director of Affirmativ Health. Dr. Kennedy also serves as a Co-Editor-In-Chief at Aging Cell.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwardsDr. David Sinclair on the Information Theory of AgingLifespan Extension Advocacy Foundation2024-03-01 | On this Journal Club, hosted by Dr. Oliver Medvedik, we discuss a new paper that includes Dr. David Sinclair among its authors. We take a deep dive into this more recent aging theory, which explains aging as a loss of information that leads to old age, ill health, and ultimately death. There are researchers working on solutions to this loss of information; join us as we review this paper and see how it stacks up against other popular theories.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ LEAF / Lifespan.io is a 501(c)(3) nonprofit organization. Everything we've done thus far and everything we will do in the future is thanks to your support - please stand with us to fight the diseases of aging and increase healthy human lifespan. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero ► Make a one-time donation and learn about other ways to support us here: http://lifespan.io/support ► Learn more, and help us #CrowdsourceTheCure: lifespan.io ► Subscribe: http://www.youtube.com/user/LifespanIOEpigenetics Clocks to Identify Novel Ani-Aging Interventions: Dr. Steve Horvath at EARD 2023Lifespan Extension Advocacy Foundation2024-02-08 | Dr. Steve Horvath of Altos Labs presents "Epigenetics Clocks to Identify Novel Anti-Aging Interventions" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
Summary ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Steve Horvath is a German–American aging researcher, geneticist, and biostatistician. He is a professor at the University of California, Los Angeles known for developing the Horvath aging clock, which is a highly accurate molecular biomarker of aging, and for developing weighted correlation network analysis. His work on the genomic biomarkers of aging, the aging process, and many age-related diseases/conditions has earned him several research awards. Horvath is a principal investigator at the anti-aging startup Altos Labs and co-founder of the nonprofit Clock Foundation.
#longevity #EARD2023 #desci #decentralized #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwardsStarting a Longevity City: Niklas Anzinger and Laurence Ion Introduce Vitalia at EARD 2023Lifespan Extension Advocacy Foundation2024-01-26 | Niklas Anzinger of Infinita VC and Laurence Ion of Vita Dao discuss the latest longevity pop-up city project, called Vitalia, on the Caribbean island of Roatán.
Summary ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Vitalia will bring together 200+ entrepreneurs, artists, scientists, and enthusiasts for 2 months to live together, work together, and set the foundations for an epic permanent city to rejuvenate the world.
The mission? To extend healthy lifespan for all - by the people, for the people, to seed a permanent city fostering drug development at warp speed, starting with a permanent district on Roatán, then expand to new locations where self-governing cities can be built.
Vitalia's first pop-up city will be taking place during January and February of 2024.
#longevity #EARD2023 #desci #decentralized #nft #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwardsUsing A.I. & Blockchain to Target Aging: Kennedy Schaal at EARD 2023Lifespan Extension Advocacy Foundation2024-01-18 | Kennedy Schaal presents "Using Advanced A.I. and Blockchain Technology to Targey Aging" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
Summary ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Kennedy Schaal is the founder and CEO of Rejuve Biotech, an AI-driven therapeutics discovery company solving the problems for longevity and age-associated diseases.
By using advanced Artificial Intelligence to combine data from the Methuselah Flies with data from people, Rejuve.Bio can shorten the drug discovery pipeline and rapidly develop novel therapeutics to help people live longer. They have two high-impact and novel data sources, as well as unique artificial intelligence technology. First and foremost, they are the sole owner of data from the Methuselah Flies (fruit flies) that have been bred for longevity. Second, because flies have a shorter life cycle, they can be tested for longevity much faster than other animal models. Rejuve Biotech has the unique ability to test multiple interventions and treatment combinations over the course of a fruit fly's life and in various aspects of its life (e.g., mating, disease resistance). In addition, they also have quick access to Crowdsourced Human Data collected by a partner company, Rejuve Network.
Kennedy Schaal is an accomplished biotechnology executive with a strong leadership track record in applied genomic research and Artificial Intelligence at the frontier of longevity science. She is also a multi-published author on the science of longevity and applied genomics trials. Kennedy is also a world-leading expert on genomic selection and breeding for innovative Drosophila Methuselah Flies, which together with applied Artificial Intelligence solve many of today’s pain points in longevity research, with the potential for massive impact on the health and lifespan of people across the planet. Experienced Laboratory Director and Chief Biologist with a demonstrated history of working in the biotechnology industry. Strong research professional skilled in evolutionary biology, genetics, and the study of aging-related diseases.
#longevity #EARD2023 #desci #decentralized #nft #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #biotech #biotechnology #longevity #longevitylifestyle #stayhealthy #healthscience #rejuvenation #agingbackwardsA New Molecule for Fighting the Aging Hallmark of Mitochondrial DysfunctionLifespan Extension Advocacy Foundation2024-01-02 | This Journal Club, hosted by Dr. Oliver Medvedik, discusses a molecule that plays a role in regulating mitophagy, the maintenance of mitochondrial function through removing damaged mitochondria. While this study was conducted in worms, it opens up research into methods for potentially treating people.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ LEAF / Lifespan.io is a 501(c)(3) nonprofit organization. Everything we've done thus far and everything we will do in the future is thanks to your support - please stand with us to fight the diseases of aging and increase healthy human lifespan. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero ► Make a one-time donation and learn about other ways to support us here: http://lifespan.io/support ► Learn more, and help us #CrowdsourceTheCure: lifespan.io ► Subscribe: http://www.youtube.com/user/LifespanIOEARD 2023 Panel Discussion: Is Aging Truly Reversible?Lifespan Extension Advocacy Foundation2023-12-21 | Dr. Oliver Medvedik, Dr. Aubrey de Grey, Dr. Peter Fedichev, Dr. Hanadie Yousef, Reason, and Dr. Hans Keirstead debate whether or not aging is truly reversible at the Longevity+DeSci Summit NYC (EARD 2023).
Summary ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Dr. Oliver Medvedik earned his Ph.D. at Harvard Medical School in the Biomedical and Biological Sciences program. Oliver is presently the Director of the Kanbar Center for Biomedical Engineering at The Cooper Union, where he carries out research on improving gene targeting in mammalian cells, enzymatic oligonucleotide synthesis, and other bioengineering projects with undergraduate and graduate students at the Albert Nerken School of Engineering. Dr. Medvedik is also the co-founder of the community biotechnology laboratory, Genspace, located in Brooklyn, where he continues to serve on its board of directors. In addition, Dr. Medvedik is also co-founder and vice-president of the non-profit organization LEAF (Life Extension Advocacy Foundation), where he serves on the board of directors.
Dr. Aubrey de Grey is a pillar of the longevity community. Dr. de Grey works on the development of medical innovations that can postpone all forms of age-related ill-health. His main focus is on rejuvenation: that is, the active repair of the various types of molecular and cellular damage which eventually cause age-related disease and disability, as opposed to the mere retardation of the accumulation of such damage. He is currently the President and Chief Scientific Officer of the Longevity Escape Velocity (LEV) Foundation.
Dr. Peter Fedichev is an entrepreneur and scientist who co-founded three biotech companies: Quantum Pharmaceuticals, a drug discovery company, and Gero, a longevity startup, and GlyNeura, a biotech-pharma company aiming to cure Neurodegenerative Diseases. His scientific background lies in the fields of condensed matter physics, biophysics, and bioinformatics. His dream is to beat aging and experience life in space.
Dr. Handie Yousef is a leading expert on the biology of aging and mechanisms underlying tissue degeneration with over two decades of experience in biomedical research. In 2018, she launched Juvena Therapeutics, a venture-backed biotechnology company mapping the therapeutic potential of secreted proteins to develop biologics that prevent, reverse, and cure chronic, metabolic, and age-related diseases.
Reason is co-founder and CEO of Repair Biotechnologies. He has been an active angel investor in the longevity industry since its earliest days, with investments including Oisin Biotechnologies and Leucadia Therapeutics. He is a long-standing and well-connected patient advocate for aging research, involved in numerous fundraising and outreach initiatives conducted by organizations such as the Methuselah Foundation and SENS Research Foundation since the early 2000s. He is also the founder and writer of Fight Aging!, a noted news and commentary website in the biotechnology community.
Dr. Hans Keirstead is an internationally known stem cell expert and has led therapy development for cancer, immune disorders, motor neuron diseases, spinal cord injury, and retinal diseases. He is the Chairman and CEO of AIVITA Biomedical. Dr. Keirstead's work in spinal cord injury earned him the distinction of being one of the 100 top scientists of the year in Discover Magazine. He was featured on 60 Minutes in a full segment covering his treatment for spinal cord injury. Dr. Keirstead and his research have also appeared in Newsweek, Inc. Magazine, WIRED, Esquire, The NY Times, TIME Magazine, Men’s Vogue, Science, and The American Spectator, amongst other national publications.
#longevity #EARD2023 #desci #decentralized #nft #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #researchLongevity Molecule Project, Machine Learning, & Funding via IP-NFTs: Dr. Morten Scheibye-KnudsenLifespan Extension Advocacy Foundation2023-12-19 | Dr. Morten Scheibye-Knudsen presents "The Longevity Molecule Project, Machine Learning, and Funding Research via Intellectual Property NFTs at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
Summary ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Dr. Morten Scheibye-Knudsen runs the Schiebye-Knudsen lab at the University of Copenhagen, is the Chief Scientific Officer of the Healthy Longevity Clinic, organizes the long-running ARDD conference, and serves as president of the Nordic Aging Society.
Dr. Scheibye-Knudsen believes that aging is the largest risk factor for most diseases, and damage to our genome is a likely cause of aging. His work focuses on exploring the physiological consequences of DNA damage and what we can do to intervene in genotoxic insults.
His goal is to understand, modulate, and perhaps treat aging and age-related diseases.
#longevity #EARD2023 #desci #decentralized #nft #biotechnology #biology #healthscience #livelonger #agingbackwards #lifespan #healthspan #dna #dnarepairVitamin B12 Is Critical for Cellular ReprogrammingLifespan Extension Advocacy Foundation2023-12-14 | On this Journal Club hosted by Dr. Oliver Medvedik, we discussed a paper showing that vitamin B12 is drained by partial cellular reprogramming and that restoring its levels may be critical to the success of reprogramming strategies.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ LEAF / Lifespan.io is a 501(c)(3) nonprofit organization. Everything we've done thus far and everything we will do in the future is thanks to your support - please stand with us to fight the diseases of aging and increase healthy human lifespan. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero ► Make a one-time donation and learn about other ways to support us here: http://lifespan.io/support ► Learn more, and help us #CrowdsourceTheCure: lifespan.io ► Subscribe: http://www.youtube.com/user/LifespanIOLongevity Storytelling: How Media Shapes Progress (EARD 2023)Lifespan Extension Advocacy Foundation2023-12-14 | Tim Maupin, Namir Khaliq, and Isen Robbins uncover the profound relationship between entertainment and science, and how Hollywood's portrayal of longevity can drive funding, mold public perception, and catalyze advancements in the field.
Summary ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Tim Maupin is a New York City based director, visual effects artist and Emmy award winning cinematographer. He has also directed multiple short films that have played in a variety of festivals including Sedona International Film Festival, Nantucket, SeriesFest, San Diego Film Festival, St. Louis International Film Festival, IndieMemphis, Atlanta Shortfest, The 3D Film Festival at Sundance, and has won awards for best dramatic short film, cinematography, and visual effects. His latest short film, the 392% Kickstarter funded and staff picked "The Last Generation to Die" is currently being adapted and in development as his first feature.
Namir Khaliq is the founder of Protostellar Media, a production company designed specifically to help scientists tell stories about their work. The company provides the groundwork for scientists and science communicators to establish themselves as part of the creative process for film and television, with current partners including Daniel Kahneman, Nick Bostrom, Richard Dawkins, Helen Fisher, The Santa Fe Institute, and the Life Extension Advocacy Foundation. Prior to Protostellar, Namir worked in feature film and scripted television development at Imagine Entertainment, the multi-Academy and Emmy Award winning production company of director Ron Howard and producer Brian Grazer, where he helped develop films such as 13 Lives (Amazon), The Beanie Bubble (Apple), and Friday Night Lights (Universal), and television shows such as Filthy Rich (Fox), Genius (Nat Geo), and Under the Banner of Heaven (FX). He previously worked in film development, production, and sales at companies including Mosaic Media Group, Everyman Pictures, Funny or Die, and VMI Worldwide.
Isen Robbins co-founded Intrinsic Value Films and has been producing quality films for more than twenty years. Of his 40+ films, Ten have premiered at the Sundance Film Festival. His films have been to 100's of festivals and been distributed worldwide, having won many awards and numerous nominations. Accolades include winning a Sloan Sundance award twice, a Sundance Special Grand Jury Prize, and six nominations each at the Gotham and Independent Spirit awards. He is a Sundance & Film Independent fellow.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Lifespan.io, a 501(c)(3) nonprofit organization. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/support ► Subscribe: youtube.com/user/LifespanIO?sub_confirmation=1 ► Learn more, and help us: lifespan.io #blockchain #nft #web3 #DeSci #lifeextension #Longevity #Weavechain #decentralized #healthdata #biology #Lifespan #proofofphlanthropy #PoPNFT #PoP #EARD2023Understanding the Mechanisms of Lifespan Control: Dr. Vadim Glayshev at EARD 2023Lifespan Extension Advocacy Foundation2023-12-12 | Dr. Vadim Gladyshev presents "Understanding the Mechanisms of Lifespan Control Through Longevity Signatures" at the Longevity+DeSci Summit NYC (EARD 2023) hosted by Lifespan.io.
Summary ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Dr. Vadim Gladyshev is a Professor of Medicine at Brigham and Women’s Hospital, Harvard Medical School, and an Associate Member of the Broad Institute. He is also Director of the Center for Redox Medicine. Dr. Gladyshev’s lab applies high-throughput and computational approaches to understand the mechanisms of aging, control of lifespan, and the redox regulation of cellular processes. His lab recently developed biomarkers of mouse aging based on blood DNA methylation patterns. Dr. Gladyshev has published approximately 300 articles and has been elected as an AAAS fellow. He is a 2013 recipient of the NIH Director’s Pioneer Award to study the mechanisms of longevity.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Lifespan.io, a 501(c)(3) nonprofit organization. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/support ► Subscribe: youtube.com/user/LifespanIO?sub_confirmation=1 ► Learn more, and help us: lifespan.io #blockchain #nft #web3 #DeSci #lifeextension #Longevity #Weavechain #decentralized #healthdata #biology #Lifespan #proofofphlanthropy #PoPNFT #PoP #EARD2023Preparing for a Longevity Future with DeSci: Todd White at EARD 2023Lifespan Extension Advocacy Foundation2023-12-07 | Todd White of VitaDAO gives the opening keynote speech at the Longevity+DeSci Summit NYC (EARD 2023).
Summary ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ A seasoned business executive and early-stage investor, Todd has over 26 years of experience in start-up technology and biotech companies, where he has held C-level management roles and served as an executive advisor. His experience in corporate strategy, operations and venture financing, combined with his passion for healthspan-focused science, has found him working at the intersection of the global decentralized science (“DeSci”) and cryptocurrency eco-systems - an area which has as its constituents many longevity advocates. Currently, Todd serves as the Managing Director of the Vitality Healthspan Foundation, is an ODLB Fellow, and is the Operations Steward for VitaDAO.
VitaDAO is a decentralized autonomous organization that uses blockchain technology to manage its governance and internal structure. By using a blockchain to irrevocably record and determine corporate decisions, it becomes impossible for these decisions to be later overturned by administrative middlemen. Like other DAOs, VitaDAO replaces leadership with direct democracy by giving its stakeholders an opportunity to participate in the process, conducting votes through the blockchain that determine the direction of the organization. People and other organizations can contribute one of three things to receive tokens that signify their stake in the DAO: work, funding, or research.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Lifespan.io, a 501(c)(3) nonprofit organization. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/support ► Subscribe: youtube.com/user/LifespanIO?sub_confirmation=1 ► Learn more, and help us: lifespan.io #blockchain #nft #web3 #DeSci #lifeextension #Longevity #Weavechain #decentralized #healthdata #biology #Lifespan #proofofphlanthropy #PoPNFT #PoP #EARD2023ARPA-H Program Manager 101 at the Longevity+DeSci Summit NYC (EARD2023)Lifespan Extension Advocacy Foundation2023-11-22 | ARPA-H, the Advanced Research Projects Agency for Health, runs an exclusive Program Manager 101 Workshop at EARD 2023, sharing insights, answering questions, and debunking misconceptions about programs they are looking to fund, what it takes to be a PM, and more. Mission Office Presidential Innovation Fellow Dr. Arunan Skandarajah in conversation with Lifespan.io Executive Director Stephanie Dainow.
Summary ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ ARPA-H is a US government research funding agency modeled after DARPA (Defense Advanced Research Projects Agency). ARPA-H is committed to supporting high-impact research to drive transformative, sustainable, and equitable biomedical and health breakthroughs for everyone, shaping the future of healthcare and biomedical innovation. They are seeking the most innovative approaches to tackle the most challenging health issues, leveraging advances in research for real-world impact.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Lifespan.io, a 501(c)(3) nonprofit organization. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/support ► Subscribe: youtube.com/user/LifespanIO?sub_confirmation=1 ► Learn more, and help us: lifespan.io #blockchain #DeSci #lifeextension #Longevity #decentralized #longevity #biomarkers #lifespan #lifespandesciSavva Kerdemelidis at EARD 2022: Using Financial Innovation to Incentivize Longevity MedicineLifespan Extension Advocacy Foundation2023-11-21 | Savva Kerdemelidis presents "Using Financial Innovation to Incentivize Longevity Medicine" at the Ending Age-Related Diseases Conference 2022, by Lifespan.io.
SUMMARY ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Savvak Kerdemelidis is a commercial/IP/IT/crypto consultant legal counsel, NZ/AU Patent and Trade Mark Attorney, LLM, BSc, with 18+ years experience working with software and technology companies in the UK, EU, US, AU and NZ. He advises several DeSci/DeFi projects including VitaDAO.com, Molecule.to, Kuva.com and Amon.tech.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Lifespan.io, a 501(c)(3) nonprofit organization. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero ► Subscribe: youtube.com/user/LifespanIO ► Learn more, and help us: lifespan.io #longevity #biotechnology #aging #biology #healthscience #biomarkers #cryptocurrency #lifeextension #lifespan #antiagingGarri Zmudze at EARD 2022: Funding Impactful and Accessible Longevity R&DLifespan Extension Advocacy Foundation2023-11-20 | Garri Zmudze presenting "Funding Impactful and Accessible R&D" at the Ending Age-Related Diseases 2022, by Lifespan.io.
SUMMARY ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Garri is a seasoned business angel with an extensive track record in tech business and an early investor in science-intensive ventures, such as Insilico Medicine and Basepaws. Prior to founding LongeVC, he co-founded Longenesis — a medical technology startup company working towards providing a technological bridge between Healthcare institutions and the BioTech industry with an aim to help identify and unlock the hidden value of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those in need. In 2021, Garri became the Executive Coordinator of the Longevity Science Foundation — a Swiss non-profit organization advancing human longevity by funding research and development of medical technologies to extend the healthy human lifespan to more than 120 years. Driven and resilient, Garri is passionate about longevity, aging research, and personalized medicine.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Lifespan.io, a 501(c)(3) nonprofit organization. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero ► Subscribe: youtube.com/user/LifespanIO ► Learn more, and help us: lifespan.io #longevity #biotechnology #aging #biology #healthscience #biomarkers #lifeextension #lifespan #antiaging #futureDr. Michael West at EARD22: Novel Therapeutics Targeting AgingLifespan Extension Advocacy Foundation2023-11-03 | Dr. Michael West presents "Novel Therapeutics Targeting Aging" at the Ending Age-Related Diseases 2022 Conference.
SUMMARY ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Michael D. West is a gerontologist, and a pioneer in stem cells, cellular aging and telomerase. He is the founder and CEO of AgeX Therapeutics, a startup focused on the field of interventional gerontology, and Co-CEO of its parent company, BioTime, Inc.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Lifespan.io, a 501(c)(3) nonprofit organization. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero ► Subscribe: youtube.com/user/LifespanIO ► Learn more, and help us: lifespan.io #longevity #biotechnology #aging #biology #healthscience #biomarkers #cryptocurrency #lifeextension #lifespan #antiagingDr. Eric Morgen on The BioAge Platform: From Biomarkers to Drug Trials and Back at EARD 2022Lifespan Extension Advocacy Foundation2023-11-02 | Dr. Eric Morgen of BioAge presents "The BioAge Platform: From Biomarkers to Drug Trials and Back" at the Ending Age-Related Diseases 2022 Conference.
SUMMARY ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ In Dr. Eric Morgen's speech at BioAge, he discusses the BioAge platform, rooted in human omics data, which is used to generate biomarkers and shed light on mechanisms related to aging. BioAge is a clinical-stage biotechnology company focused on developing therapeutics that target the root causes of aging. Dr. Morgen emphasizes the importance of extending human healthspan and lifespan by addressing aging mechanisms and shares inspiring examples from nature.
The speech highlights the data-driven approach employed by BioAge, which leverages artificial intelligence and multiomics data to decode biomarkers and aging biology. The platform collects data from healthy aging cohorts and identifies key molecular differences associated with varying aging trajectories. It delves into the natural human experiment that occurs as people age.
Dr. Morgen provides insights into the power of AI and multiomics to discover aging biomarkers, functional relationships, and underlying mechanisms. The platform identifies potential drug targets, such as apelin, and the talk emphasizes the importance of translating findings from animal models to human therapeutics.
The speech concludes by discussing how the platform's biomarkers can inform clinical trials and enhance patient selection and monitoring. Ultimately, BioAge aims to help patients "die young as late as possible." ___________________________________________
Eric Morgen, MD, MPH, FRCPC, is Co-founder and COO at BioAge Labs, a clinical-stage biopharmaceutical company advancing a broad pipeline of therapeutics to treat and prevent age-related diseases and extend human healthspan and lifespan. BioAge’s computational platform is rooted in longitudinal ‘omics and clinical data spanning more than 40 years and provides a powerful approach to select drug targets that can improve the way we age. Eric’s oversees the company’s clinical, computational, and cohort-based activities.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Lifespan.io, a 501(c)(3) nonprofit organization. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero ► Subscribe: youtube.com/user/LifespanIO ► Learn more, and help us: lifespan.io #longevity #biotechnology #aging #biology #healthscience #biomarkers #startups #crypto #cryptocurrency #lifeextension #lifespanThe Conboys Discuss DNA Methylation Clocks and Their LimitationsLifespan Extension Advocacy Foundation2023-11-01 | On this Journal Club hosted by Dr. Oliver Medvedik, we discussed the new paper from Conboy et al. which examines current DNA methylation clocks and their limitations in the context of aging. They also developed a “noise barometer” to measure the epigenetic impact of aging. We were joined by two of the authors of the paper, Drs. Irina and Michael Conboy.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ LEAF / Lifespan.io is a 501(c)(3) nonprofit organization. Everything we've done thus far and everything we will do in the future is thanks to your support - please stand with us to fight the diseases of aging and increase healthy human lifespan. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero ► Make a one-time donation and learn about other ways to support us here: http://lifespan.io/support ► Learn more, and help us #CrowdsourceTheCure: lifespan.io ► Subscribe: http://www.youtube.com/user/LifespanIOKeynote: Dr. Tobias Reichmuth on Longevity: The New Crypto (EARD 2022)Lifespan Extension Advocacy Foundation2023-11-01 | Dr. Tobias Reichmuth, founding partner of Maximon, presents his keynote speech at EARD 2022 entitled Longevity: The New Crypto.
SUMMARY ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Dr. Tobias Reichmuth discusses the intersection of blockchain technology and longevity. He, with a background in the crypto industry, highlights the potential impact of cryptocurrencies and blockchain on longevity research and investment. Dr. Reichmuth describes his journey from the crypto world to longevity and his involvement in building companies focused on longevity. He also touches on the limited financial support from the crypto community for longevity research, noting that while some donations have been made, they are not yet at the same scale as those in the cryptocurrency space. Dr. Reichmuth introduces Maximon, a company builder for longevity startups, and mentions several longevity-related companies they are working on, emphasizing the importance of science-based, scalable, and quick-to-market business ideas. He also stresses the significance of creating a supportive ecosystem in the longevity field.
Dr. Tobias Reichmuth is a founding partner at Maximon-- The Longevity Company Builder. Tobias has been building companies since he was 21 years old. He exited his first start-up in 2003, thereafter built Europe’s leading climate-change infrastructure fund SUSI Partners, co-founded Crypto Finance Group and The Singularity Group, and has invested in more than 20 start-ups. In 2020 he launched the Longevity Investors Conference together with Marc P. Bernegger. Tobias is a “lion” at Switzerland’s TV investor show “Höhle der Löwen” (Shark Tank) and aims at a healthy 120 years of life.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Lifespan.io, a 501(c)(3) nonprofit organization. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero ► Subscribe: youtube.com/user/LifespanIO ► Learn more, and help us: lifespan.io #longevity #biotechnology #aging #biology #healthscience #maximon #startups #crypto #cryptocurrency #lifeextension #lifespan #desciLongevity+DeSci Summit NYC 2023 RecapLifespan Extension Advocacy Foundation2023-10-30 | Longevity+DeSci Summit NYC 2023 Recap
Missed our Longevity+DeSci Summit NYC on August 10-11, 2023? Don't worry, we've got you covered! Join us for an exhilarating recap of this transformative event by Lifespan.io where researchers, innovators, and visionaries converged to explore the frontiers of longevity biotech and decentralized science.
Lifespan.io is a nonprofit organization dedicated to advancing the field of aging research and pioneering innovative approaches to extend healthy lifespans. With a vision of transforming the way we perceive and address age-related diseases, Lifespan.io brings together researchers, entrepreneurs, investors, and the public to collaborate and support cutting-edge initiatives. Through crowdfunding campaigns, educational content, and community-building efforts, Lifespan.io empowers individuals to become active contributors in the quest to conquer aging. By fostering a collaborative ecosystem and leveraging emerging technologies, we strive to accelerate breakthroughs in longevity science for a healthier, more vibrant future.
#Longevity #DeSci #lifeextension #decentralized #Lifespan #EARD2023 #biotechnology #healthscienceRejuvenating the Heart with Extracellular Vesicles from Stem CellsLifespan Extension Advocacy Foundation2023-10-02 | On this Journal Club hosted by Dr. Oliver Medvedik, we look at a recent study published in Nature, in which extracellular vesicles derived from neonatal cardiac progenitors produced significant rejuvenation in old rats and human cells.
HOW CAN YOU SUPPORT US? ▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀ LEAF / Lifespan.io is a 501(c)(3) nonprofit organization. Everything we've done thus far and everything we will do in the future is thanks to your support - please stand with us to fight the diseases of aging and increase healthy human lifespan. ► Support us with monthly donations by becoming a Lifespan Hero: lifespan.io/hero ► Make a one-time donation and learn about other ways to support us here: http://lifespan.io/support ► Learn more, and help us #CrowdsourceTheCure: lifespan.io ► Subscribe: http://www.youtube.com/user/LifespanIO